U.S. markets closed

Calumet Specialty Products Partners, L.P. (CLMT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.62+0.12 (+2.18%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close5.50
Open5.45
Bid5.50 x 1000
Ask5.85 x 1100
Day's Range5.45 - 5.65
52 Week Range2.01 - 6.64
Volume121,756
Avg. Volume222,488
Market Cap442.161M
Beta (5Y Monthly)2.71
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 29, 2016
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • New Strong Sell Stocks for May 4th
    Zacks

    New Strong Sell Stocks for May 4th

    ABMD, CLMT, FLMN, GRUB, and IHG have been added to the Zacks Rank #5 (Strong Sell) List on May 4, 2021

  • What Does Calumet Specialty's Debt Look Like?
    Benzinga

    What Does Calumet Specialty's Debt Look Like?

    Shares of Calumet Specialty (NASDAQ:CLMT) rose by 8.78% in the past three months. Before we understand the importance of debt, let us look at how much debt Calumet Specialty has. Calumet Specialty's Debt According to the Calumet Specialty's most recent balance sheet as reported on March 3, 2021, total debt is at $1.35 billion, with $1.32 billion in long-term debt and $34.60 million in current debt. Adjusting for $109.40 million in cash-equivalents, the company has a net debt of $1.24 billion. Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents include cash and any liquid securities with maturity periods of 90 days or less. Total debt equals current debt plus long-term debt minus cash equivalents. To understand the degree of financial leverage a company has, shareholders look at the debt ratio. Considering Calumet Specialty's $1.81 billion in total assets, the debt-ratio is at 0.75. As a rule of thumb, a debt-ratio more than one indicates that a considerable portion of debt is funded by assets. A higher debt-ratio can also imply that the company might be putting itself at risk for default, if interest rates were to increase. However, debt-ratios vary widely across different industries. A debt ratio of 40% might be higher for one industry and normal for another. Why Shareholders Look At Debt? Debt is an important factor in the capital structure of a company, and can help it attain growth. Debt usually has a relatively lower financing cost than equity, which makes it an attractive option for executives. However, due to interest-payment obligations, cash-flow of a company can be impacted. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital. Looking for stocks with low debt-to-equity ratios? Check out Benzinga Pro, a market research platform which provides investors with near-instantaneous access to dozens of stock metrics - including debt-to-equity ratio. Click here to learn more. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For March 3, 2021Calumet Specialty Earnings Preview© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Benzinga

    Calumet Specialty Earnings Preview

    Calumet Specialty (NASDAQ:CLMT) unveils its next round of earnings this Wednesday, March 03. Get prepared with Benzinga's ultimate preview for Calumet Specialty's Q4 earnings. What Are Earnings, Net Income, And Earnings Per Share? Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS. Earnings And Revenue Analysts are predicting Calumet Specialty will report a loss of $0.79 per share on revenue of $488.34 million. Calumet Specialty EPS in the same period a year ago totaled $0.23. Revenue was $774.80 million. What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter? Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin. View more earnings on CLMT If the company were to report earnings in line when it publishes results Wednesday, quarterly profit would be down 243.48%. Revenue would have fallen 36.97% from the same quarter last year. Here is how the company's EPS has stacked up against analyst estimates in the past: Quarter Q3 2020 Q2 2020 Q1 2020 Q4 2020 EPS Estimate -0.38 -0.22 -0.18 -0.35 EPS Actual -0.49 -0.25 0.28 -0.23 Revenue Estimate 531.73 M 462.41 M 659.44 M 689.68 M Revenue Actual 568.00 M 453.70 M 692.60 M 774.80 M Stock Performance Over the last 52-week period, shares of Calumet Specialty are up 15.94%. Do not be surprised to see the stock move on comments made during its conference call. Calumet Specialty is scheduled to hold the call at 09:00:00 ET and can be accessed here. See more from BenzingaClick here for options trades from BenzingaCECO Environmental's Earnings: A PreviewPreview: Dycom Industries's Earnings© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.